Current location - Plastic Surgery and Aesthetics Network - Clothing company - Yunnan province centralized drug collection platform
Yunnan province centralized drug collection platform
Yunnan centralized drug purchasing platform is a centralized purchasing platform established by Yunnan provincial government to reduce drug prices and improve purchasing efficiency.

I. Functions and characteristics of the platform

Yunnan centralized drug procurement platform integrates the demand of drug procurement in the whole province, forming scale effect, so as to conduct centralized negotiation and procurement with drug suppliers. The platform has the following functions and features:

1. Centralized procurement: the platform summarizes the drug procurement needs of medical institutions at all levels in the province, forms a unified purchase order, realizes centralized procurement and improves procurement efficiency.

2. Openness and transparency: The platform adopts public bidding and competitive negotiation to ensure the openness, fairness and impartiality of the procurement process and prevent corruption.

3. Optimize supply chain management: The platform establishes a long-term and stable cooperative relationship with drug suppliers, optimizes supply chain management, and ensures stable drug quality and supply.

4. Reduce drug prices: Through centralized procurement negotiation, the platform helps reduce drug procurement costs, thus reducing drug prices and reducing the burden on patients.

Second, the platform operation process

The operation flow of Yunnan centralized drug procurement platform mainly includes the following steps:

1. demand summary: medical institutions at all levels submit the drug procurement demand to the platform, and the platform summarizes and analyzes the demand.

2. Bidding negotiation: The platform issues bidding announcement or conducts competitive negotiation according to the summarized procurement demand, and invites drug suppliers to participate in bidding or negotiation.

3. Selection of evaluation: The platform organizes experts to evaluate the bidding or negotiation results, and selects drug suppliers with high quality and low price for cooperation.

4. Contract procurement: The platform signs a procurement contract with the selected drug supplier and purchases drugs according to the contract.

5. Distribution settlement: the drug supplier distributes the drugs to the designated medical institutions according to the contract requirements, and the platform settles the payment with the supplier.

Third, the significance and influence of the platform.

The establishment and implementation of the centralized drug procurement platform in Yunnan Province has had a positive impact on drug procurement and medical system in Yunnan Province:

1. Reduce drug prices: Through centralized procurement negotiation, the platform can effectively reduce drug procurement costs, thus reducing drug prices and benefiting patients.

2. Improve procurement efficiency: The platform realizes centralization and standardization of procurement process, improves procurement efficiency and reduces procurement cost.

3. Ensuring drug demand: The platform can ensure that the drug demand of medical institutions is met and the drug rights and interests of patients are protected.

4. Promote the development of pharmaceutical industry: The establishment of the platform will help promote the healthy development of pharmaceutical industry, optimize industrial structure and improve drug quality.

To sum up:

Through centralized procurement, openness and transparency, and optimization of supply chain management, Yunnan centralized drug procurement platform has achieved the purpose of reducing drug prices and improving procurement efficiency, which has had a positive impact on drug procurement and medical system in Yunnan Province. The establishment of the platform is helpful to ensure the drug demand of medical institutions, reduce the drug burden of patients and promote the healthy development of the pharmaceutical industry.

Legal basis:

People's Republic of China (PRC) Drug Administration Law

Article 5 provides that:

The state encourages the research and creation of new drugs and protects the legitimate rights and interests of citizens, legal persons and other organizations in the research and development of new drugs.

People's Republic of China (PRC) Drug Administration Law

Article 26 provides that:

When purchasing drugs, medical institutions must establish and implement the system of inspection and acceptance of incoming goods, and verify the marks such as drug certificate; Do not meet the requirements, shall not be purchased and used.